505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA
Announces Closing of $11.0 Million Private Placement
Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments
Artelo Biosciences Enters into $337,300 Securities Purchase Agreements
Reports on Financial Statements and Going Concern Matter
Announces Reverse Stock Split
Other Events
Equity Purchase Agreement with Square Gate Capital for $25 Million
Shareholder votes
FY 2024
Q3
Q2
Q1
Effectiveness Notice
Notice of Exempt Offering of Securities
RW
S-1
Amended Registration Statement for Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload